CHN
Example 1
Test Liposcale®
REPORT DATE
25/03/2025
Lipidic Contour
The Liposcale Test® is an advanced lipoprotein analysis based on Nuclear Magnetic Resonance (NMR) spectroscopy that directly measures lipid content and the number and size of lipoprotein particles. The Liposcale report is divided in two sections. The first section includes information on the traditional lipid panel, concentrations of large, intermediate, and small VLDL, LDL, and HDL particles, average sizes of VLDL, LDL and HDL particle, and well as the lipidic contour. The second section includes information on the extended lipoprotein panel -(including cholesterol and triglyceride content in VLDL, IDL, LDL and HDL particles)-, and patient clinical outcome.
Registro Mercantil de BARCELONA T 38980 , F 109, S 8, H B 65850, I/A 49(29.03.18) C.I.F. A-08222465
PARAMETER
RESULT³
Small LDL particles
LDL-C
LDL Cholesterol
LDL-TG
LDL Triglycerides
Rem C
Remnant cholesterol
VLDL-TG
VLDL Triglycerides
HDL-Ø
HDL particle size
M-HDL-P
Medium HDL particles
HDL-C
HDL Cholesterol
HDL-TG/HDL-C
Ratio of HDL Triglycerides/HDL Cholesterol
< 200
LDL-Ø
LDL particle size
< 100
Moderate/low CV risk
RECOMMENDED VALUE Cardiovascular risk
Lipidic profile¹ TOTAL CHOLESTEROL
S-LDL-P
Very high-risk
High-risk
257 mg/dL < 55
Moderate/low-risk
LDL CHOLESTEROL²
167 mg/dL
HDL CHOLESTEROL
68 mg/dL
> ♂40 ♀50
TRIGLYCERIDES
79 mg/dL
< 150
REMNANT CHOLESTEROL
22 mg/dL
< 30
NON-HDL CHOLESTEROL
189 mg/dL
< 85
< 70
4
< 100
< 130
Particle number (associated with cardiovascular risk) VLDL PARTICLES
31 nmol/L
< 70
LDL PARTICLES
1571 nmol/L
< 700
< 1000
< 1150
LDL PARTICLES (SMALL)
716 nmol/L
< 380
< 550
< 630
HDL PARTICLES
32 µmol/L
> 24
HDL PARTICLES (MEDIUM)
12.0 µmol/L
> 8.2
High CV risk Very high CV risk
What does the Lipidic Contour represent? The lipidic contour is a graphical model which allows a quick and comprehensive evaluation of a patient's lipoprotein metabolism beyond classical parameters. It combines the information from the 10 variables associated with cardiovascular (CV) risk, which are represented in colours: The variable contributes to increase CV risk. The area of the region delimited by the orange curve will decrease when the value is: > the recommended value for S-LDL-P, LDL-C, LDL-TG, Rem C, VLDL-TG and HDL-TG/HDL-C < the recommended value for HDL-Ø, M-HDL-P, HDL-C and LDL-Ø Opposite case. The variable is associated with lower CV risk.
Particle size (diameter) VLDL PARTICLES
42.24 nm
42.03 - 42.36
LDL PARTICLES
21.43 nm
> 20.91
HDL PARTICLES
8.3 nm
> 8.21
Patient outcome is similar to the recommended value. The orange contour represents a moderate/low-risk patient situation compared to the values of a general population of 6.000 individuals (black circle). Orange discontinuous contours represent both high and very high-risk patients (see legend).
¹All parameters have been determined by NMR spectroscopy. There may be variability when compared to other analytical methods. ²LDL cholesterol is calculated directly and does not include IDL cholesterol ³Traffic light colours above have been established for moderate/low-risk patients. 4
Risk categories were defined according to ESC/EAS Guidelines for the Management of Dyslipidaemias (2019). Laboratorios Rubió: Indústria, 29 - Pol. Ind. Comte de Sert 08755 Castellbisbal - Barcelona (España) - (+34) 937 722 509
1/4 Example 1